Hematology/Oncology

Top Story

VIDEO: Some women with early-stage breast cancer can safely avoid adjuvant chemotherapy

May 4, 2016

NEW ORLEANS — Hatem Soliman, MD, assistant member of the women’s oncology and breast cancer department at Moffitt Cancer Center, discusses the implications of the results from the randomized phase 3 MINDACT trial, presented at the American Association for Cancer Research Annual Meeting.

Meeting News Coverage

Ibrutinib dose adherence associated with higher PFS for CLL

May 4, 2016
Taking ibrutinib at full dose and on schedule improved PFS among patients with chronic lymphocytic leukemia, according to an analysis of the RESONATE trial presented at…
FDA News

FDA grants priority review to olaratumab for soft tissue sarcoma

May 4, 2016
The FDA granted priority review for olaratumab in combination with doxorubicin to treat patients with advanced soft tissue sarcoma who are not responsive to curative…
FDA News

FDA grants priority review to Blinctyo to treat pediatric B-cell precursor ALL

May 4, 2016
The FDA granted priority review to blinatumomab for the treatment of pediatric and adolescent patients with Philadelphia chromosomenegative relapsed or refractory B-cell…
In the Journals

Chemoradiotherapy does not prolong OS in locally advanced pancreatic cancer

May 4, 2016
The addition of radiation to chemotherapy failed to improve OS for patients with locally advanced pancreatic cancer, according to the results of the randomized…
More News Headlines »
CME Video

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Video
Meeting News Coverage

VIDEO: New approaches demonstrate potential to exploit immune system to treat cancer

April 30, 2016
More »
Featured
CME Video

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan